Zobrazeno 1 - 10
of 11
pro vyhledávání: '"R T Bachand"'
Publikováno v:
Irish medical journal. 84(1)
A total of 2,351 adult patients were recruited into a multi-centre open general practice study to investigate the safety and efficacy of Clarithromycin 250 mg b.d. for seven days in the management of acute mild to moderate respiratory tract infection
Autor:
R. T. Bachand, A.Y. Dubourg
Publikováno v:
The Journal of international medical research. 18(3)
Tolerance of long-term buflomedil was assessed by compiling safety data (adverse effects, vital signs and clinical laboratory results) from three multicentre clinical trials in patients with intermittent claudication or Alzheimer's disease-type senil
Autor:
T. B. Sebree, C. M. MacLeod, James T. Doluisio, M. B. Szalkowski, R. S. Geary, Salomon A Stavchansky, R. T. Bachand, R. Heilman
Publikováno v:
Biopharmaceutics & Drug Disposition. 10:229-237
A single-blind study was conducted in 10 healthy male subjects. Each subject was tested with four single oral doses of capsules containing 25, 50, 100, 200mg almitrine bismesylate and one dose of placebo. Blood samples were drawn as a function of tim
Publikováno v:
European journal of respiratory diseases. Supplement. 126
Publikováno v:
La Revue du praticien. 33(1-2)
Publikováno v:
Annals of internal medicine. 105(3)
Almitrine bismesylate was studied for its effects on hypoxemia in 67 patients with chronic obstructive lung disease in a placebo-controlled, double-blind study. Arterial Po2 rose by 11.2 mm Hg (p less than 0.05) in 21 patients receiving 100 mg twice
Autor:
C. M. MacLeod, T. B. Sebree, James T. Doluisio, M. B. Szalkowski, R. S. Geary, R. T. Bachand, Salomon A Stavchansky, R. Heilman
Publikováno v:
Biopharmaceuticsdrug disposition. 10(3)
Bioavailability and bioequivalency studies of almitrine bismesylate from U.S. manufactured film coated, waxed, 50 mg tablets were compared in 34 normal healthy volunteers to 50 mg European film coated, waxed and unwaxed, tablets and a 0.5 per cent (w
Publikováno v:
European journal of respiratory diseases. Supplement. 126
Almitrine bismesylate was administered to young, healthy, non-smoking male subjects as single oral doses, multiple oral doses and multiple oral doses with food. A variety of physiological parameters and blood parameters were tested at specified times
Autor:
T. B. Sebree, R. S. Geary, R. T. Bachand, C. M. MacLeod, Salomon A Stavchansky, James T. Doluisio, R. Heilman, M. B. Szalkowski
Publikováno v:
Biopharmaceuticsdrug disposition. 10(3)
A double blind study utilizing orally administered almitrine bismesylate was conducted involving 36 stable chronic obstructive pulmonary disease (COPD) patients with hypoxia and with and without hypercapnia. The patients received 50 mg tablets twice
Publikováno v:
The American review of respiratory disease. 134(5)
Patients with congenital central hypoventilation syndrome (CCHS) lack hypercapnic and hypoxic stimulation of ventilation but have demonstrated carotid body function in response to hyperoxia and to pharmacological stimulation with doxapram. This study